Please use this identifier to cite or link to this item:
Type: Artigo
Title: Synergistic Effect Of Kir Ligands Missing And Cytomegalovirus Reactivation In Improving Outcomes Of Haematopoietic Stem Cell Transplantation From Hla-matched Sibling Donor For Treatment Of Myeloid Malignancies
Author: Cardozo
Daniela Maira; Marangon
Amanda Vansan; da Silva
Rodrigo Fernandes; Penteado Aranha
Francisco Jose; Laguila Visentainer
Jeane Eliete; Alves Bonon
Sandra Helena; Botelho Costa
Sandra Cecilia; Martins Miranda
Eliana Cristina; de Souza
Carmino Antonio; Guimaraes
Abstract: The goal of this study was to evaluate the influence of KIR-HLA genotypes on the outcome of patients undergoing treatment for haematological malignancies by non-T-depleted lymphocyte haematopoietic stem cell transplantation (HSCT) from HLA-matched sibling donors. The prospective study was conducted at the Center of Hematology, University of Campinas, and 50 patients and their donors were followed up from 2008 to 2014. KIR and HLA class I genes were genotyped and patients grouped based on the presence of KIR ligands combined with KIR genotype of their respective donors. Patients with all KIR ligands present (n = 13) had a significantly higher (p = 0.04) incidence of acute graft-versus-host-disease (GVHD) than patients with one or more KIR ligands missing (n = 37). The overall survival following transplantation of patients with myeloid malignancies (n = 27) was significantly higher (p = 0.035) in the group with one or more KIR ligands missing (n = 18) than in the group with all ligands present (n = 9). Presence of KIR2DS2 was associated with a worsening of HSCT outcome while reactivation of cytomegalovirus (CMV) infection improved the outcome of patients with one or more KIR ligands missing. Our results indicate that KIR-HLA interactions affect the outcome of the HLA-matched transplantation, particularly in patients with myeloid malignancies. (C) 2016 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.
Subject: Natural Killer Cells
Myeloid Leukaemia
Editor: Elsevier Science INC
New York
Rights: fechado
Identifier DOI: 10.1016/j.humimm.2016.07.003
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000383313200008.pdf747.92 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.